176 related articles for article (PubMed ID: 28060750)
41. Negative regulation of beta4 integrin transcription by homeodomain-interacting protein kinase 2 and p53 impairs tumor progression.
Bon G; Di Carlo SE; Folgiero V; Avetrani P; Lazzari C; D'Orazi G; Brizzi MF; Sacchi A; Soddu S; Blandino G; Mottolese M; Falcioni R
Cancer Res; 2009 Jul; 69(14):5978-86. PubMed ID: 19567674
[TBL] [Abstract][Full Text] [Related]
42. Repression of the antiapoptotic molecule galectin-3 by homeodomain-interacting protein kinase 2-activated p53 is required for p53-induced apoptosis.
Cecchinelli B; Lavra L; Rinaldo C; Iacovelli S; Gurtner A; Gasbarri A; Ulivieri A; Del Prete F; Trovato M; Piaggio G; Bartolazzi A; Soddu S; Sciacchitano S
Mol Cell Biol; 2006 Jun; 26(12):4746-57. PubMed ID: 16738336
[TBL] [Abstract][Full Text] [Related]
43. Transcriptional regulation of ferritin and antioxidant genes by HIPK2 under genotoxic stress.
Hailemariam K; Iwasaki K; Huang BW; Sakamoto K; Tsuji Y
J Cell Sci; 2010 Nov; 123(Pt 22):3863-71. PubMed ID: 20980392
[TBL] [Abstract][Full Text] [Related]
44. HIPK2 Phosphorylates the Microtubule-Severing Enzyme Spastin at S268 for Abscission.
Pisciottani A; Biancolillo L; Ferrara M; Valente D; Sardina F; Monteonofrio L; Camerini S; Crescenzi M; Soddu S; Rinaldo C
Cells; 2019 Jul; 8(7):. PubMed ID: 31284535
[TBL] [Abstract][Full Text] [Related]
45. Heat shock modulates the subcellular localization, stability, and activity of HIPK2.
Upadhyay M; Bhadauriya P; Ganesh S
Biochem Biophys Res Commun; 2016 Apr; 472(4):580-4. PubMed ID: 26972256
[TBL] [Abstract][Full Text] [Related]
46. PML tumor suppressor is regulated by HIPK2-mediated phosphorylation in response to DNA damage.
Gresko E; Ritterhoff S; Sevilla-Perez J; Roscic A; Fröbius K; Kotevic I; Vichalkovski A; Hess D; Hemmings BA; Schmitz ML
Oncogene; 2009 Feb; 28(5):698-708. PubMed ID: 19015637
[TBL] [Abstract][Full Text] [Related]
47. p300-mediated acetylation increased the protein stability of HIPK2 and enhanced its tumor suppressor function.
Choi JR; Lee SY; Shin KS; Choi CY; Kang SJ
Sci Rep; 2017 Nov; 7(1):16136. PubMed ID: 29170424
[TBL] [Abstract][Full Text] [Related]
48. Restoring wtp53 activity in HIPK2 depleted MCF7 cells by modulating metallothionein and zinc.
Puca R; Nardinocchi L; Bossi G; Sacchi A; Rechavi G; Givol D; D'Orazi G
Exp Cell Res; 2009 Jan; 315(1):67-75. PubMed ID: 18996371
[TBL] [Abstract][Full Text] [Related]
49. Homeodomain-interacting protein kinase 2 (HIPK2) targets beta-catenin for phosphorylation and proteasomal degradation.
Kim EA; Kim JE; Sung KS; Choi DW; Lee BJ; Choi CY
Biochem Biophys Res Commun; 2010 Apr; 394(4):966-71. PubMed ID: 20307497
[TBL] [Abstract][Full Text] [Related]
50. Control of nuclear HIPK2 localization and function by a SUMO interaction motif.
de la Vega L; Fröbius K; Moreno R; Calzado MA; Geng H; Schmitz ML
Biochim Biophys Acta; 2011 Feb; 1813(2):283-97. PubMed ID: 21145359
[TBL] [Abstract][Full Text] [Related]
51. Roscovitine-activated HIP2 kinase induces phosphorylation of wt p53 at Ser-46 in human MCF-7 breast cancer cells.
Wesierska-Gadek J; Schmitz ML; Ranftler C
J Cell Biochem; 2007 Mar; 100(4):865-74. PubMed ID: 17203463
[TBL] [Abstract][Full Text] [Related]
52. Regulation of p53 activity by HIPK2: molecular mechanisms and therapeutical implications in human cancer cells.
Puca R; Nardinocchi L; Givol D; D'Orazi G
Oncogene; 2010 Aug; 29(31):4378-87. PubMed ID: 20514025
[TBL] [Abstract][Full Text] [Related]
53. Phosphorylation-dependent control of Pc2 SUMO E3 ligase activity by its substrate protein HIPK2.
Roscic A; Möller A; Calzado MA; Renner F; Wimmer VC; Gresko E; Lüdi KS; Schmitz ML
Mol Cell; 2006 Oct; 24(1):77-89. PubMed ID: 17018294
[TBL] [Abstract][Full Text] [Related]
54. HIPK2 controls cytokinesis and prevents tetraploidization by phosphorylating histone H2B at the midbody.
Rinaldo C; Moncada A; Gradi A; Ciuffini L; D'Eliseo D; Siepi F; Prodosmo A; Giorgi A; Pierantoni GM; Trapasso F; Guarguaglini G; Bartolazzi A; Cundari E; Schininà ME; Fusco A; Soddu S
Mol Cell; 2012 Jul; 47(1):87-98. PubMed ID: 22658722
[TBL] [Abstract][Full Text] [Related]
55. Homeodomain-interacting protein kinase-2 restrains cytosolic phospholipase A2-dependent prostaglandin E2 generation in human colorectal cancer cells.
D'Orazi G; Sciulli MG; Di Stefano V; Riccioni S; Frattini M; Falcioni R; Bertario L; Sacchi A; Patrignani P
Clin Cancer Res; 2006 Feb; 12(3 Pt 1):735-41. PubMed ID: 16467083
[TBL] [Abstract][Full Text] [Related]
56. Mechanism of dual specificity kinase activity of DYRK1A.
Walte A; Rüben K; Birner-Gruenberger R; Preisinger C; Bamberg-Lemper S; Hilz N; Bracher F; Becker W
FEBS J; 2013 Sep; 280(18):4495-511. PubMed ID: 23809146
[TBL] [Abstract][Full Text] [Related]
57. How cells switch HIPK2 on and off.
Sombroek D; Hofmann TG
Cell Death Differ; 2009 Feb; 16(2):187-94. PubMed ID: 18974774
[TBL] [Abstract][Full Text] [Related]
58. Inhibition of I kappaB-alpha phosphorylation at serine and tyrosine acts independently on sensitization to DNA damaging agents in human glioma cells.
Miyakoshi J; Yagi K
Br J Cancer; 2000 Jan; 82(1):28-33. PubMed ID: 10638962
[TBL] [Abstract][Full Text] [Related]
59. Phosphorylation of nucleotide excision repair factor xeroderma pigmentosum group A by ataxia telangiectasia mutated and Rad3-related-dependent checkpoint pathway promotes cell survival in response to UV irradiation.
Wu X; Shell SM; Yang Z; Zou Y
Cancer Res; 2006 Mar; 66(6):2997-3005. PubMed ID: 16540648
[TBL] [Abstract][Full Text] [Related]
60. HIPK2: A tumour suppressor that controls DNA damage-induced cell fate and cytokinesis.
Hofmann TG; Glas C; Bitomsky N
Bioessays; 2013 Jan; 35(1):55-64. PubMed ID: 23169233
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]